Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,500
Closed -$95K 98
2024
Q1
$95K Hold
2,500
0.06% 63
2023
Q4
$93K Hold
2,500
0.05% 56
2023
Q3
$85K Hold
2,500
0.05% 59
2023
Q2
$98K Hold
2,500
0.05% 63
2023
Q1
$80K Hold
2,500
0.04% 75
2022
Q4
$78K Hold
2,500
0.04% 76
2022
Q3
$93K Hold
2,500
0.04% 66
2022
Q2
$73K Hold
2,500
0.03% 81
2022
Q1
$129K Hold
2,500
0.04% 77
2021
Q4
$126K Sell
2,500
-4,000
-62% -$224K 0.04% 76
2021
Q3
$364K Buy
6,500
+3,500
+117% +$193K 0.12% 52
2021
Q2
$177K Buy
+3,000
New +$169K 0.06% 85

Other funds holding PGNY

NKCFO LLC's PGNY Position: Q2 2024 in Review

NKCFO LLC sold out of Progyny (PGNY) in Q2 2024, closing a stake of 2,500 shares — an estimated $95K sold.

NKCFO LLC first reported a position in PGNY in Q2 2021 and held it in 12 quarters. The position peaked at $364K in Q3 2021. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • NKCFO LLC reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • NKCFO LLC sold 2,500 Progyny shares in Q2 2024, an estimated $95K.
  • NKCFO LLC first reported a position in Progyny in Q2 2021 and held it in 12 quarters.
  • NKCFO LLC's Progyny position peaked at $364K in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on NKCFO LLC's 13F filing for Q2 2024, filed 13 Aug 2024.